| dc.creator | Patoulias D., Dimosiari A., Michailidis T., Roditis P., Lampropoulos S. | en |
| dc.date.accessioned | 2023-01-31T09:46:16Z | |
| dc.date.available | 2023-01-31T09:46:16Z | |
| dc.date.issued | 2022 | |
| dc.identifier | 10.1016/j.amjcard.2022.06.022 | |
| dc.identifier.issn | 00029149 | |
| dc.identifier.uri | http://hdl.handle.net/11615/77977 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | American Journal of Cardiology | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136580425&doi=10.1016%2fj.amjcard.2022.06.022&partnerID=40&md5=30c71e8da6e4731decbd62e4676bcc3a | |
| dc.subject | empagliflozin | en |
| dc.subject | ertugliflozin | en |
| dc.subject | sodium glucose cotransporter 2 inhibitor | en |
| dc.subject | antidiabetic agent | en |
| dc.subject | cotransporter | en |
| dc.subject | glucose | en |
| dc.subject | sodium | en |
| dc.subject | all cause mortality | en |
| dc.subject | cardiovascular disease | en |
| dc.subject | cardiovascular risk factor | en |
| dc.subject | cerebrovascular disease | en |
| dc.subject | coronary artery disease | en |
| dc.subject | drug efficacy | en |
| dc.subject | drug screening | en |
| dc.subject | high risk population | en |
| dc.subject | human | en |
| dc.subject | Letter | en |
| dc.subject | non insulin dependent diabetes mellitus | en |
| dc.subject | osmotic diuresis | en |
| dc.subject | randomized controlled trial (topic) | en |
| dc.subject | risk factor | en |
| dc.subject | sleep disordered breathing | en |
| dc.subject | software | en |
| dc.subject | meta analysis | en |
| dc.subject | non insulin dependent diabetes mellitus | en |
| dc.subject | Cardiovascular Diseases | en |
| dc.subject | Diabetes Mellitus, Type 2 | en |
| dc.subject | Glucose | en |
| dc.subject | Humans | en |
| dc.subject | Hypoglycemic Agents | en |
| dc.subject | Sleep Apnea, Obstructive | en |
| dc.subject | Sodium | en |
| dc.subject | Sodium-Glucose Transporter 2 Inhibitors | en |
| dc.subject | Symporters | en |
| dc.subject | Elsevier Inc. | en |
| dc.title | Meta-analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on the Risk for New-Onset Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus Regardless of Cardiovascular Disease at Baseline | en |
| dc.type | other | en |